Covered recipient · General Payments record
VINAYAK V DONGRE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$4,793.77
- Reported across 110 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $511.83 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $131.68 | 3 |
| Kerecis Limited | $118.93 | 3 |
| Novo Nordisk AS | $87.46 | 1 |
| Paratek Pharmaceuticals, Inc. | $54.18 | 3 |
| Smith & Nephew, Inc. | $53.60 | 3 |
| MIMEDX Group, Inc. | $45.54 | 1 |
| Janssen Pharmaceuticals, Inc | $20.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $20.44 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078012688 | CMS |
| Kerecis Limited | $23.05 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120099916 | CMS |
| Kerecis Limited | $74.29 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120108799 | CMS |
| Kerecis Limited | $21.59 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120100765 | CMS |
| Lilly USA, LLC | $88.09 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135476620 | CMS |
| Lilly USA, LLC | $18.48 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135491604 | CMS |
| Lilly USA, LLC | $25.11 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135440605 | CMS |
| MIMEDX Group, Inc. | $45.54 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140258309 | CMS |
| Novo Nordisk Inc | $87.46 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097659619 | CMS |
| Paratek Pharmaceuticals, Inc. | $13.46 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113898543 | CMS |
| Paratek Pharmaceuticals, Inc. | $20.49 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113898545 | CMS |
| Paratek Pharmaceuticals, Inc. | $20.23 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113898547 | CMS |
| Smith+Nephew, Inc. | $21.19 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149516663 | CMS |
| Smith+Nephew, Inc. | $16.66 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149516661 | CMS |
| Smith+Nephew, Inc. | $15.75 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149516659 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.